retatrutide phase 3 results Doctor Reveals The MOST POWERFUL GLP-1 Yet — (28.7% Weight Loss) Retatrutide just delivered the first
Description
Triple agonists: Retatrutide (GIP/GLP-1/glucagon)
GLP-1s should only be used under the supervision of a licensed healthcare provider because they may cause gastrointestinal side effects, gallbladder disease, and, rarely, pancreatitis or thyroid C-cell tumors
Gas, bloating, or loose stools are the signal to pull back
Pay month by month for as long as you want
Simultaneous root-cause work while the medication is active, we address insulin resistance, hormonal imbalances, inflammation, gut health, sleep, and stress so the internal environment improves, not just the number on the scale
The very environment where endometriosis develops is deficient in GLP-1
